Immune Response to Intrathecal Enzyme Replacement Therapy in Mucopolysaccharidosis I Patients

Pediatric Research - United States
doi 10.1038/pr.2013.158
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I

2019English

Mucopolysaccharidosis Type II: Enzyme Replacement Therapy Efficiency

Voprosy Sovremennoi Pediatrii - Current Pediatrics
Child HealthPediatricsPerinatology
2020English

Limited Data to Evaluate Real‐World Effectiveness of Enzyme Replacement Therapy for Mucopolysaccharidosis Type I

Journal of Inherited Metabolic Disease
Genetics
2019English

Enzyme Replacement Therapy Treatment From Birth Increases Therapeutic Efficacy and Generates Tolerance to Enzyme in Canine Mucopolysaccharidosis Type I

English

Laronidase Replacement Therapy and Left Ventricular Function in Mucopolysaccharidosis I

JIMD Reports
Internal MedicineGeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2014English

Arterial Pathology in Canine Mucopolysaccharidosis-I and Response to Therapy

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2011English

Monitoring Dose Response of Enzyme Replacement Therapy in Feline Mucopolysaccharidosis Type VI by Tandem Mass Spectrometry

Pediatric Research
Child HealthPediatricsPerinatology
2004English

Pharmacoeconomic Evaluation of Drugs Used in Enzyme Replacement Therapy Mucopolysaccharidosis Type II

Pharmacoeconomics: theory and practice
2019English

Effects of Neonatal Enzyme Replacement Therapy and Simvastatin Treatment on Cervical Spine Disease in Mucopolysaccharidosis I Dogs

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy